Encouraging the use of generic medicines: implications for transition economies.
Generic drugs have a key role to play in the efficient allocation of financial resources for pharmaceutical medicines. Policies implemented in the countries with a high rate of generic drug use, such as Canada, Denmark, Germany, the Netherlands, the United Kingdom, and the United States, are reviewed, with consideration of the market structures that facilitate strong competition. Savings in these countries are realized through increases in the volume of generic drugs used and the frequently significant differences in the price between generic medicines and branded originator medicines. Their policy tools include the mix of supply-side measures and demand-side measures that are relevant for generic promotion and higher generic use. On the supply-side, key policy measures include generic drug marketing regulation that facilitates market entry soon after patent expiration, reference pricing, the pricing of branded originator products, and the degree of price competition in pharmaceutical markets. On the demand-side, measures typically encompass influencing prescribing and dispensing patterns as well as introducing a co-payment structure for consumers/patients that takes into consideration the difference in cost between branded and generic medicines. Quality of generic medicines is a pre-condition for all other measures discussed to take effect. The paper concludes by offering a list of policy options for decision-makers in Central and Eastern European economies in transition.
LSE Health and Social Care, Room J404, Cowdray House, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, United Kingdom. d.king@lse.ac.uk
Derek R
DR
King
Panos
P
Kanavos
D017046:Cost Savings; D003906:Developing Countries / Q000191:economics; D016568:Drugs, Generic / Q000191:economics* / Q000600:supply & distribution*; D004465:Economic Competition; D005060:Europe; D015276:Health Care Rationing; D006291:Health Policy; D006801:Humans; D007880:Legislation, Drug; D006113:United Kingdom; D014481:United States
D016568:Drugs, Generic